Hollow Hydroxyapatite Microspheres Loaded with rhCXCL13 to Recruit BMSC for Osteogenesis and Synergetic Angiogenesis to Promote Bone Regeneration in Bone Defects
Jianhua Zeng,Shilang Xiong,Jingyu Zhou,Peng Wei,Kai Guo,Feng Wang,Min Ouyang,Zhisheng Long,Aihua Yao,Jingtang Li,Long Xiong,Desheng Wu
DOI: https://doi.org/10.2147/ijn.s408905
IF: 7.033
2023-06-29
International Journal of Nanomedicine
Abstract:Jianhua Zeng, 1, 2, &ast Shilang Xiong, 3, &ast Jingyu Zhou, 4 Peng Wei, 4 Kai Guo, 1 Feng Wang, 1 Min Ouyang, 4 Zhisheng Long, 5 Aihua Yao, 6 Jingtang Li, 7 Long Xiong, 4 Desheng Wu 1 1 Department of Spine Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200092, China; 2 Department of Spine Surgery, People's Hospital of Ganxian District, Ganzhou, Jiangxi, 341100, China; 3 Department of Orthopedics, the First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center of Jiangxi Province, Nanchang, Jiangxi, 330006, China; 4 Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China; 5 Department of Spine Surgery, Jiangxi Provincial People's Hospital the First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330006, China; 6 School of Materials Science and Engineering, Tongji University, Shanghai, 201804, China; 7 Department of Traumatology, Jiangxi provincial People's Hospital the First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330006, China &astThese authors contributed equally to this work Correspondence: Desheng Wu; Long Xiong, Email ; Introduction: Bone tissue engineering is a promising method to treat bone defects. However, the current methods of preparing composite materials that mimic the complex structure and biological activity of natural bone are challenging for recruitment of bone marrow mesenchymal stem cells (BMSCs), which affects the application of these materials in situ bone regeneration. Hollow hydroxyapatite microspheres (HHMs) possess a natural porous bone structure, good adsorption, and slow release of chemokines, but have low ability to recruit BMSCs and induce osteogenesis. In this study, The HHM/chitosan (CS) and recombinant human C-X-C motif chemokine ligand 13 (rhCXCL13)-HHM/CS biomimetic scaffolds that optimize bone regeneration and investigated their mechanism of BMSC recruitment and osteogenesis through cell and animal experiments and transcriptomic sequencing. Methods: Evaluate the physical characteristics of the HHM/CS and rhCXCL13-HHM/CS biomimetic scaffolds through Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD), and the cumulative release curve of rhCXCL13. Transwell migration experiments and co-culture with BMSCs were conducted to study the recruitment ability and osteogenic differentiation of the scaffolds. Transcriptomic sequencing was performed to analyze the osteogenic differentiation mechanism. The osteogenesis and bone healing performance were evaluated using a rabbit radial defect model. Results: SEM demonstrated that the rhCXCL13-HHM/CS scaffold comprised hydroxyapatite microspheres in a porous three-dimensional network. The rhCXCL13 showed excellent sustained release capability. The rhCXCL13-HHM/CS scaffold could recruit BMSCs and induce bone regeneration. Transcriptome sequencing and experimental results showed that the osteogenesis mechanism of rhCXCL13-HHM/CS was through the PI3K-AKT pathway. In vivo, the rhCXCL13-HHM/CS scaffold significantly promoted osteogenesis and angiogenesis at 12 weeks after surgery. Conclusion: The rhCXCL13-HHM/CS scaffold demonstrates excellent potential for BMSC recruitment, osteogenesis, vascularized tissue-engineered bone reconstruction, and drug delivery, providing a theoretical basis for material osteogenesis mechanism study and promising clinical applications for treating large bone defects. Keywords: bone regeneration, rhCXCL13-HHM/CS scaffold, recruit BMSCs, transcriptome sequencing, bone repair Large refractory bones with poor blood circulation, large scope or weakened osteogenic capacity have been a great challenge for orthopaedic surgeons. 1 Multiple surgeries are required, resulting in poor efficacy and even amputation, which imposes a substantial economic and social burden on patients. Currently, autologous bone graft with vascular pedicle remains the gold standard for clinical bone repair. However, this operation has several disadvantages, limited quantities available, large surgical wounds, strict surgical requirements, and unsatisfying vascular ingrowth. Large bone allograft only plays a supporting role in the process due to inferior osteoinductive capability and lack of blood supply. 2,3 In bone tissue engineering, tissue engineering bone is the most promising new bone repair material. The classic tissue engineering bone contains seed cells, scaffold materials, and osteogenic related active fa -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology